| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.37 | 0.02 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |